Lyka Labs share price: corporate actions and dates 2026

Latest share price snapshot

Lyka Labs Ltd’s share price was reported at ₹75.84 as on 13 October 2026. The update appears alongside a cluster of corporate disclosures spanning board meetings, AGM scheduling, and compliance actions. For investors tracking smaller counters, these calendar events matter because they usually set the timing for results approvals and governance decisions. They also define periods when trading restrictions apply to insiders under SEBI regulations. In Lyka Labs’ case, the publicly visible trail includes notices to stock exchanges, AGM-related information, and board meeting agendas.

Stock identifiers investors track

Lyka Labs is tracked across Indian market infrastructure with multiple identifiers. The NSE symbol is LYKALABS, and the BSE scrip code is 500259. The company’s ISIN is INE933A01014. These identifiers are used for trading, settlement, and corporate action processing. They are also helpful for verifying filings and announcements across exchange portals.

Corporate action calendar: key meeting dates

The company’s corporate actions list shows several scheduled meetings and purposes, including quarterly results, audited results, AGM, and “others.” A key point for readers is that the corporate-actions listing shows a board meeting dated Aug 9, 2026 for quarterly results, while exchange-related items also reference a board meeting on Aug 10, 2026 linked to financial results and a board meeting outcome. Separately, the AGM was scheduled around early August 2026, and the company later reported shareholder voting outcomes.

47th AGM: all five resolutions passed

Lyka Labs reported that its 47th Annual General Meeting (AGM) was held on 10 August 2026. The company said all five resolutions were passed with “overwhelming” shareholder approval through e-voting. One of the items noted in the summary was approval related to a related party transaction with IPCA Laboratories. The AGM outcome is a governance milestone because it confirms shareholder consent on the set of matters presented. It also provides a formal record of approvals, which is often relevant for transactions or routine statutory business.

AGM notice: meeting held through video conferencing

Ahead of the AGM, Lyka Labs announced that the 47th AGM would be held on Monday, 10 August 2026 at 12.30 PM. The notice specified that it would be conducted through video conferencing. Such disclosures are typically important for participation logistics, including how shareholders can attend, vote, and raise queries. In the reported timeline, this AGM notice was dated 17 July 2026.

Board meetings tied to financial results

Lyka Labs’ disclosures include multiple board meetings scheduled for results approvals. One item states the board meeting was scheduled on May 25, 2026, to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. Another exchange item notes a meeting scheduled on 10 August 2026 to consider and approve financial results (as per the attached letter referenced in the notice). The corporate actions table also lists quarterly results activity around early August 2026. For investors, these dates matter because they indicate when the board is expected to review and approve results, after which exchanges receive formal filings.

Cost auditor appointment noted in March 2026

A board meeting outcome dated 31 March 2026 is described as resulting in the appointment of M/s. Nidhi Subhash Tibrewala & Co. as Cost Auditors for financial years 2025-26 and 2026-27. A separate note also says the company scheduled a board meeting for March 31, 2026 to approve the appointment of cost accountants to fill a casual vacancy for FY 2025-26 and determine remuneration. These items are part of compliance and statutory governance rather than operational performance, but they are still meaningful signals of process and oversight.

Insider trading window closure for designated persons

Lyka Labs informed the BSE and NSE that trading in the company’s securities would be closed for “Designated Persons” and their immediate relatives from Thursday, October 1, 2026. The closure was stated to remain in force until 48 hours after the announcement of the company’s unaudited financial results for the second quarter ending September 30, 2026. The disclosure references compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. For market participants, such windows are standard in listed-company compliance, but the dates help interpret insider activity restrictions around results time.

Preference share redemption agenda (September 2025)

Lyka Labs also disclosed that a board meeting was scheduled for September 29, 2025, with an agenda that included considering redemption of 1,08,570 unlisted 10% Cumulative Redeemable Preference Shares of face value ₹100 each. The total value was described as approximately ₹1.09 crore. While this relates to an earlier period than the 2026 AGM and results calendar, it is part of the company’s corporate actions trail. It can also be relevant for readers tracking capital structure changes and legacy securities.

Corporate actions at a glance

Market impact: what the disclosed items change for investors

The most concrete market data point in the provided information is the reported share price of ₹75.84 (13 October 2026). The rest of the updates are primarily event-driven disclosures that affect timing and compliance rather than immediate fundamentals. Results-related board meetings set the expected window for audited and unaudited financial filings, which can change investor focus once the numbers are released. The insider trading window closure is a standard governance step, but it clarifies when trading restrictions apply for insiders around Q2 (quarter ended September 30, 2026) results. AGM voting outcomes, including related party transaction approvals, are also relevant because they document shareholder consent on key proposals.

Why this set of events matters

Taken together, the AGM outcome, board meeting schedules, and insider trading window disclosure show a typical cadence of listed-company governance. The AGM passing all five resolutions indicates shareholder support for the proposals placed for approval, including the noted related party transaction item. Meanwhile, repeated board meeting notices for audited and quarterly results are important because they anchor the company’s financial reporting timeline. For investors and analysts following Lyka Labs, the next meaningful step in this flow is the formal release of the relevant financial results after the stated board considerations and exchange filings.

Conclusion

Lyka Labs’ recent updates focus on governance and reporting milestones, including the 47th AGM held on 10 August 2026, board meetings for results approvals, and an insider trading window closure starting 1 October 2026 tied to Q2 (ended 30 September 2026) results. The share price reference in the provided information stands at ₹75.84 as of 13 October 2026. Investors tracking the stock will typically watch for the next exchange filing that publishes the unaudited Q2 numbers and any related board outcomes, once the results are announced and the trading window reopens for designated persons after the stated period.